The Asian Network of People who Use Drugs (ANPUD) and the International Network of People who Use Drugs (INPUD), through our national network allies and colleagues, are leading a global week of action against the extrajudicial killings of people who use drugs in the Philippines. The global week of action will take place in the week beginning October 10th 2016. The week will focus actions at embassies and consulates of the Philippines around the world. You are encouraged to take the lead in identifying an appropriate date in the week for a peaceful demonstration at embassies and consulates.
On August 5, 2016, Nepalese community of people who use drugs demonstrated a peaceful protest and urgently requested that the Government of Philippines and his Excellency President Duterte call an immediate halt to the extrajudicial killing of people, and entreat instead to set science-based standards for a healthy, productive, and prosperous Philippines. Please read their press release and the petition they submitted to President Duterte via the Consulate Office of the Philippines in Kathmandu, Nepal.
Recovering Nepal, National network of Drug Users and Drug led organizations (RN), conducted Protest against program of disseminating “Hepatitis Treatment Guideline for Nepal”. Protest against Technical Team, in-front health Minister to ensure inclusion of drug user’s community and key technical activist of civil society in Nepal.
Protest was a success: Technical team conceptually agreed to revisit the process and minister also reinforced to address the voices of Civil Society.
In an open letter to Indonesian President Joko Widodo, published in the leading health journal The Lancet, a group of prominent Indonesian academics and experts have called on the government to commit to proven public health approaches to address drug use, and to urgently discontinue strategies which have been found counterproductive such as involuntary rehabilitation and the death penalty.
The Drugs Registration Board in Pakistan has decided to develop further guidelines for local manufacturers to qualify the minimum regulatory requirements for hepatitis C drug registration at the earliest by its next meeting in June 2015
Summary of generic sofosbuvir availability in India and pricing as of 18 May 2015.